Loading...
AMBU B logo

Ambu A/SInforme acción CPSE:AMBU B

Capitalización bursátil DKK 23.4b
Precio de las acciones
DKK 87.75
No disponible
1Y-17.9%
7D0%
Valor de la cartera
​
Ver

Ambu A/S

Informe acción CPSE:AMBU B

Capitalización de mercado: DKK 23.4b

Ambu (AMBU B) Resumen de Acciones

Ambu A/S, empresa de tecnología médica, desarrolla, produce y vende dispositivos médicos a hospitales, clínicas y servicios de rescate de todo el mundo. Saber más

Análisis fundamental de AMBU B
Puntuación del snowflake
Valoración3/6
Crecimiento futuro3/6
Rendimiento pasado5/6
Salud financiera6/6
Dividendos0/6

Recompensas

Cotiza un 33.6% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 19.5%

Los beneficios aumentaron un 159.1% el pasado año

Los analistas coinciden en que el precio de las acciones subirá un 30.8%

Análisis de riesgos

AMBU B ha superado nuestros controles de riesgos.

AMBU B Community Fair Values

Create Narrative

See what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.

AMBU B logo
Ambu

Rising Costs, Stricter Rules And Rivals Will Limit Market Prospects

Key Takeaways Intensifying pricing pressures and regulatory hurdles are set to challenge revenue growth and profitability for Ambu's single-use endoscopes. Advances in competing technologies and strong market competition threaten the long-term relevance and sales potential of Ambu's core product lines.
View narrative
DKK 94.54
FV
7.2% infravalorado descuento intrínseco
10.60%
Revenue growth p.a.
23
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AMBU B logo
Ambu

Expansion Of Single-use Endoscopy Will Improve Hospital Efficiency

Key Takeaways Expanding single-use endoscopy portfolio and first-mover advantages drive growth by addressing infection concerns and penetrating new clinical segments. Enhanced manufacturing, distribution, and demographic trends position Ambu for improved margins, recurring sales, and sustained long-term revenue growth.
View narrative
DKK 114.79
FV
23.6% infravalorado descuento intrínseco
10.84%
Revenue growth p.a.
57
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AMBU B logo
Ambu

Aging Global Population And Healthcare Digitalization Will Expand Single-Use Endoscopy

Key Takeaways Broad adoption of Ambu's single-use devices across departments and growing endoscopy demand are poised to outpace revenue and margin expectations. Shifting manufacturing to Mexico and digital healthcare integration uniquely position Ambu for margin expansion and premium service opportunities amid tightening infection control regulations.
View narrative
DKK 147
FV
40.3% infravalorado descuento intrínseco
12.09%
Revenue growth p.a.
6
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Competidores de Ambu A/S

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del Ambu
Precios históricos de las acciones
Precio actual de la acciónDKK 87.75
Máximo en las últimas 52 semanasDKK 143.90
Mínimo de 52 semanasDKK 80.10
Beta1.55
Cambio en 1 mes-0.28%
Variación en 3 meses-5.85%
Cambio de 1 año-17.88%
Variación en 3 años-1.40%
Variación en 5 años-66.66%
Variación desde la OPV5,024.09%

Noticias y actualizaciones recientes

An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Recent updates

An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

Dec 12
An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Nov 27
We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward

Oct 07
Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward

Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 27
Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?

Aug 11
Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Jul 12
Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

May 15
Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Feb 02
Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Jan 12
Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

Dec 31
Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?
User avatar

Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth

Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Nov 28
Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07
Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Sep 02
Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Aug 06
Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01
Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02
A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31
Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19
Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12
Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07
Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Rentabilidad de los accionistas

AMBU BDK Medical EquipmentMercado DK
7D0%-0.5%2.1%
1Y-17.9%-26.5%-25.0%

Rentabilidad vs. Industria: AMBU B superó a la industria Danish Medical Equipment, que obtuvo un rendimiento del -26.5% el año pasado.

Rentabilidad vs. Mercado: AMBU B superó al mercado Danish, que obtuvo un rendimiento del -25% el año pasado.

Volatilidad de los precios

Is AMBU B's price volatile compared to industry and market?
AMBU B volatility
AMBU B Average Weekly Movement6.0%
Medical Equipment Industry Average Movement5.1%
Market Average Movement4.3%
10% most volatile stocks in DK Market10.1%
10% least volatile stocks in DK Market2.5%

Precio estable de las acciones: AMBU B no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado Danish.

Volatilidad a lo largo del tiempo: La volatilidad semanal de AMBU B (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19375,384Britt Jensenwww.ambu.com

Ambu A/S, empresa de tecnología médica, desarrolla, produce y vende dispositivos médicos a hospitales, clínicas y servicios de rescate de todo el mundo. La empresa ofrece productos de anestesia, monitorización de pacientes y diagnóstico. También ofrece productos de endoscopia, como broncoscopios, rinolaringoscopios, duodenoscopios, gastroscopios, cistoscopios y unidades de visualización; y productos de neurología, como electrodos de EEG y EMG, inyecciones guiadas por EMG y productos de monitorización intraoperatoria.

Resumen de fundamentos de Ambu A/S

¿Cómo se comparan los beneficios e ingresos de Ambu con su capitalización de mercado?
Estadísticas fundamentales de AMBU B
Capitalización bursátilDKK 23.39b
Beneficios(TTM)DKK 609.00m
Ingresos (TTM)DKK 6.04b
38.4x
Ratio precio-beneficio (PE)
3.9x
Ratio precio-ventas (PS)

¿Está AMBU B sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de AMBU B
IngresosDKK 6.04b
Coste de los ingresosDKK 2.40b
Beneficio brutoDKK 3.63b
Otros gastosDKK 3.02b
BeneficiosDKK 609.00m

Últimos beneficios comunicados

Sep 30, 2025

Próxima fecha de beneficios

Feb 04, 2026

Beneficios por acción (BPA)2.28
Margen bruto60.18%
Margen de beneficio neto10.09%
Ratio deuda/patrimonio0.08%

¿Cómo se ha desempeñado AMBU B a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.5%
Rentabilidad actual por dividendo
18%
Ratio de pagos

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2025/12/27 23:02
Precio de las acciones al final del día2025/12/23 00:00
Beneficios2025/09/30
Ingresos anuales2025/09/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Ambu A/S está cubierta por 14 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
null nullABG Sundal Collier
Michael HealyBerenberg
Susannah LudwigBernstein